Investor.sagerx.com

Investor Sage Rx. Inc.'s business for stockholders, potential investors, and financial analysts.

Never miss Investor.sagerx.com updates: Start reading the news feed of Investor Sage Rx right away! Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Investor.sagerx.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Investor Sage Rx

Subscribe to related news

Sage Therapeutics receives fast track designation for status epilepticus therapy
via newdrugapprovals.wordpress

SAGE-547 ALLOPREGNANOLONE Sage Therapeutics (Originator) Sage Therapeutics For Epilepsy, status epilepticus SGE-102; SAGE-547; allopregnanolone; allosteric GABA A receptor modulators (CNS disorders), Sage Therapeutics receives fast track designation...
SAGE Therapeutics to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference
via virtual.tdprofiti

CAMBRIDGE, Mass., June 3, 2015 (GLOBE NEWSWIRE) — SAGE Therapeutics (Nasdaq:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced that Jeff...
Course Descriptions
via eastwest

Accounting AC101 | Fall/Winter FINANCIAL ACCOUNTING I 4 CREDITS | COREQUISITE: MT155 will also be examination of the standard setting process, the accrual process, and preparation of financial statements. This course uses a rues-based approach to...
Chi-Med 2016 Interim Results
via saudiindustrydaily

HONG KONG, CHINA—(Marketwired – Aug 2, 2016) – Hutchison China Meditech Limited ( NASDAQ : HCM ) Nasdaq: HCM Hutchison China MediTech Limited (“Chi–Med”) Reports Interim Results for the Six Months Ended June 30, 2016, Provides 2016 Financial Guidance...
Recorded Speakers and Sessions
via ldnresearchtrust

As part of the LDN 2017 Conference we are proud to offer the recorded presentation as outlined below. Cancer: Using the Latest Ideas in Immunotherapy to Improve Outcomes, Survival, and Quality of Life 30m Paul Anderson, NMD Cancer is a pervasive...

Investor.sagerx.com popular pages

Investor Relations | Sage Therapeutics, Inc.

The Investor Relations website contains information about Sage Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial Results (NASDAQ:SAGE)

.gnw_table_border_collapse td.gnw_heading, .gnw_heading {font: 16px Arial; text-align: center} .gnw_table_border_collapse td.gnw_subhead, .gnw_subhead {font: 12px Arial; text-align: center} .g...

Analyst Coverage - Sage Therapeutics, Inc.

The Investor Relations website contains information about Sage Therapeutics, Inc. business for stockholders, potential investors, and financial analysts.